E-LIB Suche - Ergebnisse für: Hemenway, Molly

1

PALC-03. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR..:

Winzent-Oonk, Shelby ; Vallejos, Chelsea ; Hemenway, Molly..
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

2

CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL ..:

Dorris, Kathleen ; Mettetal, Ashley ; Hemenway, Molly...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

3

Integration of single-nuclei RNA-sequencing, spatial transc..:

Amani, Vladimir ; Riemondy, Kent A. ; Fu, Rui...
Acta Neuropathologica Communications. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

The incidence and characterization of weight gain associate..:

Rush, Cassandra ; Sabus, Ashley ; Bradley, Zanette Kanani..
Pediatric Blood & Cancer. 70 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

5

NFB-22. Neurofibromatosis Therapeutics Program: Development..:

Hemenway, Molly ; Foreman, Nicholas ; Kristinsson, Sara
Neuro-Oncology. 24 (2022) Supplement_1 - p. i132-i132 , 2022

Link: https://doi.org/10.1093/..

6

SWK-09. Baseline Survey of Hematology/Oncology/Cellular The..:

Hemenway, Molly ; Raybin, Jennifer ; Waters, Melissa
Neuro-Oncology. 24 (2022) Supplement_1 - p. i182-i182 , 2022

Link: https://doi.org/10.1093/..

7

LGG-42. Thromboembolic toxicity observed with concurrent tr..:

Chan, Priya ; Sabus, Ashley ; Hemenway, Molly...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i97-i98 , 2022

Link: https://doi.org/10.1093/..

8

NURS-04. Marijuana, Hemp, and the Child with Cancer: Educat..:

Hemenway, Molly
Neuro-Oncology. 24 (2022) Supplement_1 - p. i146-i146 , 2022

Link: https://doi.org/10.1093/..

9

SWK-10. Survivorship: Education, Clinical Guidelines, and T..:

Hemenway, Molly ; Dorris, Kathleen ; Foreman, Nicholas...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i182-i183 , 2022

Link: https://doi.org/10.1093/..

10

NFB-14. Post-operative use of MEK inhibitors to prevent reb..:

Chan, Priya ; Hemenway, Molly ; McMahon, Kathleen...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i131-i131 , 2022

Link: https://doi.org/10.1093/..

11

RARE-32. Phase 0 and feasibility single-institution clinica..:

Dorris, Kathleen ; Mettetal, Ashley ; Dahl, Nathan...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i17-i17 , 2022

Link: https://doi.org/10.1093/..

12

NFB-21. Neurofibromatosis Type I in the Setting of Neuro-On..:

Hemenway, Molly
Neuro-Oncology. 24 (2022) Supplement_1 - p. i132-i132 , 2022

Link: https://doi.org/10.1093/..

13

Preclinical and clinical investigation of intratumoral chem..:

Dorris, Kathleen ; Wempe, Michael F ; Vibhakar, Rajeev...
Neuro-Oncology Advances. 2 (2020) 1 - p. , 2020

Link: https://doi.org/10.1093/..

14

MODL-01. SAFETY IN CONCOMITANT USE OF MEK AND BRAF INHIBITO..:

Winzent, Shelby ; Sabus, Ashley ; Hemenway, Molly..
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii411-iii412 , 2020

Link: https://doi.org/10.1093/..

15

NURS-12. MAKING SURVIVORS HEALTHIER: A MULTIDISCIPLINARY AP..:

Hemenway, Molly ; Dorris, Kathleen ; Rydin, Amy...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii423-iii423 , 2020

Link: https://doi.org/10.1093/..